Bob Duggan

Grant Cardone chats with Bob Duggan, CEO of Summit Therapeutics, a successful business titan. They discuss Duggan's entrepreneurial journey, the importance of continuous improvement, investing strategies, and the power of thinking big. Duggan shares valuable insights on achieving success and leaving a positive impact on the world.

In this discussion, Matt Herper, a STAT reporter focused on cancer immunotherapy, joins Bob Duggan, co-CEO of Summit, to delve into recent turbulence in cancer treatments. They explore a groundbreaking drug that outperforms Merck's Keytruda in lung cancer trials. The talk shifts to the complexities faced by Moderna, balancing vaccine production with drug development despite having ample cash reserves. Finally, they examine ethical concerns surrounding obesity drugs tested in children and their implications for future treatments.